These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33354818)

  • 21. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
    Mattei PL; Corey KC; Kimball AB
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):333-7. PubMed ID: 23425140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between quality of life and the severity of psoriasis in Turkey.
    Çakmur H; Derviş E
    Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palmoplantar pustulosis - a cross-sectional analysis in Germany.
    Wilsmann-Theis D; Jacobi A; Frambach Y; Philipp S; Weyergraf A; Schill T; Steinz K; Gerdes S; Mössner R
    Dermatol Online J; 2017 Apr; 23(4):. PubMed ID: 28541870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psoriatic patients: Analysis of patients dissatisfied with their management].
    Mahé E; Maccari F; Beauchet A; Quiles-Tsimaratos N; Beneton N; Parier J; Barthelemy H; Goujon-Henry C; Chaby G; Thomas-Beaulieu D; Géner G; Wagner L; Pallure V; Devaux S; Vermersch-Langlin A; Pfister P; Jégou J; Livideanu C; Sigal ML;
    Ann Dermatol Venereol; 2017; 144(8-9):497-507. PubMed ID: 28624255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of interdisciplinary vs. dermatological care of moderate-to-severe psoriasis: a pragmatic randomised controlled trial.
    Schmitt J; Wozel G; Garzarolli M; Viehweg A; Bauer M; Leopold K
    Acta Derm Venereol; 2014 Mar; 94(2):192-7. PubMed ID: 23995849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of Life in Patients with Psoriasis Seen in the Department of Dermatology, Antananarivo, Madagascar.
    Sendrasoa FA; Razanakoto NH; Ratovonjanahary V; Raharolahy O; Ranaivo IM; Andrianarison M; Rakotoarisaona MF; Rakotonaivo NA; Sata M; Ramarozatovo LS; Rapelanoro RF
    Biomed Res Int; 2020; 2020():9292163. PubMed ID: 33015185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
    Reich K; Krüger K; Mössner R; Augustin M
    Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and factors associated with depression and anxiety in patients with psoriasis.
    Pollo CF; Miot HA; Matos TDS; de Souza JM; Jorge MFS; Miot LDB; Meneguin S
    J Clin Nurs; 2021 Feb; 30(3-4):572-580. PubMed ID: 33258200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
    He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatology Life Quality Index In Patients Of Psoriasis And Its Correlation With Severity Of Disease.
    Khan JM; Rathore MU; Tahir M; Abbasi T
    J Ayub Med Coll Abbottabad; 2020; 32(1):64-67. PubMed ID: 32468758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of Psychosocial Health in Psoriatic Patients: A Multi-national Study.
    Lesner K; Reich A; Szepietowski JC; Dalgard FJ; Gieler U; Tomas-Aragones L; Lien L; Poot F; Jemec GB; Misery L; Szabó C; Linder D; Sampogna F; Evers AWM; Halvorsen JA; Balieva F; Lvov A; Marron SE; Altunay IK; Finlay AY; Salek SS; Kupfer J
    Acta Derm Venereol; 2017 Nov; 97(10):1182-1188. PubMed ID: 28795763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of quality of life and psychological status in adults with psoriasis.
    Kwan Z; Bong YB; Tan LL; Lim SX; Yong ASW; Ch'ng CC; Tan MP; Ismail R
    Arch Dermatol Res; 2018 Jul; 310(5):443-451. PubMed ID: 29687328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alexithymia and psoriasis: a case-control study of 53 patients].
    Masmoudi J; Maalej I; Masmoudi A; Rached H; Rebai A; Turki H; Jaoua A
    Encephale; 2009 Feb; 35(1):10-7. PubMed ID: 19250988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psychiatric comorbidities of psoriasis: pilot study].
    Parafianowicz K; Sicińska J; Moran A; Szumański J; Staniszewski K; Rudnicka L; Kokoszka A
    Psychiatr Pol; 2010; 44(1):119-26. PubMed ID: 20449985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).
    Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):452-6. PubMed ID: 24911993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A European subset analysis from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country-specific features: results from psoriasis patients in Spain.
    Puig L; van de Kerkhof PCM; Reich K; Bachelez H; Barker J; Girolomoni G; Paul C
    J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):1176-1182. PubMed ID: 28271561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for depression in psoriasis patients during a dermatological consultation: A first step towards treatment.
    Kromer C; Mohr J; Celis D; Poortinga S; Gerdes S; Mössner R; Wilsmann-Theis D
    J Dtsch Dermatol Ges; 2021 Oct; 19(10):1451-1461. PubMed ID: 34467650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life in persons living with psoriasis patients.
    Martínez-García E; Arias-Santiago S; Valenzuela-Salas I; Garrido-Colmenero C; García-Mellado V; Buendía-Eisman A
    J Am Acad Dermatol; 2014 Aug; 71(2):302-7. PubMed ID: 24836080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice.
    Spelman L; Su JC; Fernandez-Peñas P; Varigos GA; Cooper AJ; Baker CS; Lee M; Ring JM; Thirunavukkarasu K
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2184-91. PubMed ID: 26370225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI).
    Mease PJ
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S64-85. PubMed ID: 22588772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.